ORIC Pharmaceuticals, Inc.
- ORIC
- NASDAQ
- Biotechnology
- Oncology Drugs
- Small Molecule Therapeutics
$12.35
Today −3.29%Quote Oct 16, 2026, 08:00 PM UTC
−4.11%over the last month
Max drawdown −16.2%From 1-month high −8.5%3 months +18.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.28B
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$23.50
+90.3% from here
Floor
$11.86
4.0% below price
Where the price sits
10 analysts
Analyst range, low to high
$15.00$27.00
- Price $12.35
- Resistance $12.61–$12.74
- Consensus $23.50
The price is right under resistance. Analysts' average target sits about 90% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ORICPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
111
Founded
2014